Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: VENATORX PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2023-09-15 to 2026-12-31
Current total value of award: $26449853
Description: THE PURPOSE OF THIS NO-COST MODIFICATION IS TO UPDATE ARTICLE G.7 INDIRECT COST RATES BASED ON DOCUMENTATION FROM NIH DATED APRIL 23, 2025, AND ARTICLE I.1 FAR 52.252-52, CLAUSES INCORPORATED BY REFERENCE (FEBRUARY 1998) IN ACCORDANCE WITH (I) FAR CL